4 sources checked · source map still forming · 2h ago
Needs Review
Company behind 2022 formula shortage to pay $384M over tainted formula
Abbott Laboratories agreed to pay $384M to settle federal and state allegations of knowingly selling potentially contaminated infant formula, stemming from unsanitary conditions at its Michigan and Arizona plants.
0 Left4 Center0 Right
Needs review.This source map is too narrow, too early, or mixed-format to trust yet.
NEEDS REVIEW
As of September 15, 2026 at 6:30 PM, this is how Optics News reads the wording differences in this story.
What happenedAbbott Laboratories agreed to pay $384M to settle federal and state allegations of knowingly selling potentially contaminated infant formula, stemming from unsanitary conditions at its Michigan and Arizona plants.
The headline splitThe headlines are mostly aligned. The differences are small wording choices, not a major framing split.
Match confidenceDeveloping. Only 4 sources are matched, and the source map is still narrow. Useful to watch, not enough to draw conclusions yet.
Same-event confidenceDeveloping
Not enough sources yet to confirm this is the same specific event.
Framing confidenceHidden
Wording-gap score not shown — same-event match is still developing.
Wording differs, but the match is too narrow to read confidently yet.
WHAT EACH SIDE EMPHASIZED
Left / center-leftNo matching source in this bucket yet.
Optics keeps watching for pickup.
CenterCompany behind 2022 formula shortage to pay $384M over tainted formula
The Star-Ledger (NJ.com) · Center · News report
Right / center-rightNo matching source in this bucket yet.
Company behind 2022 formula shortage to pay $384M over tainted formula
Abbott Laboratories agreed to pay $384M to settle federal and state allegations of knowingly selling potentially contaminated infant formula, stemming from unsanitary conditions at its Mich...
Company behind 2022 formula shortage to pay $384M over tainted formula
Abbott Laboratories agreed to pay $384M to settle federal and state allegations of knowingly selling potentially contaminated infant formula, stemming from unsanitary conditions at its Mich...
Company behind 2022 formula shortage to pay $384M over tainted formula
Abbott Laboratories agreed to pay $384M to settle federal and state allegations of knowingly selling potentially contaminated infant formula, stemming from unsanitary conditions at its Mich...
Company behind 2022 formula shortage to pay $384M over tainted formula
Abbott Laboratories agreed to pay $384M to settle federal and state allegations of knowingly selling potentially contaminated infant formula, stemming from unsanitary conditions at its Mich...
